Sagespring Wealth Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$232K Sell
4,811
-2,812
-37% -$131K ﹤0.01% 739
2025
Q4
$369K Sell
7,623
-109
-1% -$5.4K 0.01% 562
2025
Q3
$365K Sell
7,732
-6,957
-47% -$336K 0.01% 544
2025
Q2
$710K Buy
14,689
+3,167
+27% +$162K 0.02% 358
2025
Q1
$639K Buy
11,522
+1,806
+19% +$97.8K 0.02% 334
2024
Q4
$469K Buy
+9,716
New +$494K 0.01% 365

Other funds holding SNY

Sagespring Wealth Partners's SNY Position: Q1 2026 in Review

Sagespring Wealth Partners reduced its Sanofi (SNY) stake by 37% in Q1 2026, selling an estimated $131K and leaving 4,811 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #739.

Sagespring Wealth Partners first reported a position in SNY in Q4 2024 and has held it in 6 quarters since. The position peaked at $710K in Q2 2025. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Sagespring Wealth Partners held 4,811 shares of Sanofi worth $232K as of Q1 2026.
  • Sagespring Wealth Partners sold 2,812 Sanofi shares in Q1 2026, an estimated $131K.
  • Sanofi made up ﹤0.01% of Sagespring Wealth Partners's portfolio in Q1 2026, its #739 holding.
  • Sagespring Wealth Partners first reported a position in Sanofi in Q4 2024 and has held it in 6 quarters since.
  • Sagespring Wealth Partners's Sanofi position peaked at $710K in Q2 2025.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Sagespring Wealth Partners's 13F filing for Q1 2026, filed 7 May 2026.